BRPI1008280A2 - Formulações prebióticas e métodos mde uso - Google Patents

Formulações prebióticas e métodos mde uso

Info

Publication number
BRPI1008280A2
BRPI1008280A2 BRPI1008280-8A BRPI1008280A BRPI1008280A2 BR PI1008280 A2 BRPI1008280 A2 BR PI1008280A2 BR PI1008280 A BRPI1008280 A BR PI1008280A BR PI1008280 A2 BRPI1008280 A2 BR PI1008280A2
Authority
BR
Brazil
Prior art keywords
methods
prebiotic formulations
prebiotic
formulations
Prior art date
Application number
BRPI1008280-8A
Other languages
English (en)
Inventor
Andrew J Ritter
Dennis Savaiano
David Barnes
Todd Robert Klaenhammer
Original Assignee
Ritter Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ritter Pharmaceuticals Inc filed Critical Ritter Pharmaceuticals Inc
Publication of BRPI1008280A2 publication Critical patent/BRPI1008280A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A01N43/08—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with oxygen as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
BRPI1008280-8A 2009-02-24 2010-02-16 Formulações prebióticas e métodos mde uso BRPI1008280A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15515009P 2009-02-24 2009-02-24
US27262209P 2009-10-13 2009-10-13
PCT/US2010/000447 WO2010098822A1 (en) 2009-02-24 2010-02-16 Prebiotic formulations and methods of use

Publications (1)

Publication Number Publication Date
BRPI1008280A2 true BRPI1008280A2 (pt) 2015-08-25

Family

ID=42631174

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008280-8A BRPI1008280A2 (pt) 2009-02-24 2010-02-16 Formulações prebióticas e métodos mde uso

Country Status (14)

Country Link
US (9) US8492124B2 (pt)
EP (1) EP2400839B1 (pt)
JP (4) JP2012518635A (pt)
KR (3) KR20190000937A (pt)
CN (2) CN102404990A (pt)
AU (2) AU2010218439B2 (pt)
BR (1) BRPI1008280A2 (pt)
CA (2) CA2984935C (pt)
ES (1) ES2600960T3 (pt)
GB (1) GB2480042B (pt)
IL (2) IL214806B (pt)
SG (3) SG2014014435A (pt)
WO (1) WO2010098822A1 (pt)
ZA (1) ZA201106066B (pt)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
CA2984935C (en) 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US10501817B2 (en) 2010-03-16 2019-12-10 Imperial Sugar Company Process for the manufacture of co-crystallized sucrose natural sweeteners and the products thereof
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9427012B2 (en) * 2010-08-10 2016-08-30 R.P. Scherer Technologies, Llc Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
US20120107395A1 (en) * 2010-11-01 2012-05-03 Viva Pharmaceutical Inc. Probiotic Soft Gel Compositions
CA2825473C (en) 2011-01-25 2021-02-16 Austrianova Singapore Pte Ltd. Protection of microbial cells from acidic degradation
CN111518866A (zh) * 2011-03-01 2020-08-11 群体创新有限责任公司 用于治疗与致病生物膜相关之病症的材料和方法
WO2013082562A1 (en) * 2011-11-30 2013-06-06 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
JP5931449B2 (ja) * 2012-01-11 2016-06-08 日東電工株式会社 医薬組成物及びその製造方法
EP3145403A4 (en) 2012-03-14 2018-01-24 Anastasia Rigas Breath analyzer and breath test methods
US20150250407A1 (en) * 2012-03-14 2015-09-10 Anastasia Rigas Breath analyzer and breath test methods
CN102757929B (zh) * 2012-07-16 2013-07-24 江苏远山生物技术有限公司 促进酪酸梭菌增殖的方法
ES2611912T3 (es) * 2012-11-08 2017-05-11 Ludwig Stocker Hofpfisterei Gmbh Microorganismos Lactobacillus sanfranciscensis a partir de una masa madre
CA2906987A1 (en) * 2013-03-15 2014-09-18 Mylan Inc. Manufacturing process for effervescent dosage forms
US11116235B2 (en) 2013-05-24 2021-09-14 General Mills, Inc. Food products with yogurt whey
GB201319538D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
WO2015153841A1 (en) * 2014-04-04 2015-10-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
WO2015157428A1 (en) * 2014-04-08 2015-10-15 Mayo Foundation For Medical Education And Research Ingestible capsule
EP3164145A4 (en) 2014-07-01 2018-01-17 Probi Usa, Inc. Bi-layer dual release probiotic tablets
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
CN104694415A (zh) * 2014-12-04 2015-06-10 北京农学院 一种降胆固醇副干酪乳杆菌益生菌巧克力的制作方法
US20160158174A1 (en) * 2014-12-09 2016-06-09 Intercontinental Great Brands Llc Enteric-Coated Functional Food Ingredients And Methods For Making The Enteric-Coated Functional Food Ingredients
EP3229595B1 (en) * 2014-12-12 2021-02-03 The Regents of the University of California Reduction of milk glycans and their degradation products in the neonate gut
US10190142B2 (en) * 2016-01-25 2019-01-29 King-Prebiotics Biotechnology (Tw) Co., Ltd. High-purity galactooligosaccharide compositions, preparations, and applications thereof
CA3017371A1 (en) * 2016-03-11 2017-09-14 Evolve Biosystems, Inc. Food compositions for weaning
US10973792B2 (en) 2019-02-13 2021-04-13 Axcess Global Sciences, Llc Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
US11185518B2 (en) 2017-12-19 2021-11-30 Axcess Global Sciences, Llc S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10736861B2 (en) 2016-03-11 2020-08-11 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis
US10973786B2 (en) 2016-03-11 2021-04-13 Axcess Global Sciences, Llc R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US20230346721A1 (en) 2018-04-18 2023-11-02 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US12496283B2 (en) 2016-04-19 2025-12-16 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US12533346B2 (en) 2016-04-19 2026-01-27 Axcess Global Sciences, Llc Administration of berberine metabolites
US12521378B2 (en) 2016-04-19 2026-01-13 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans
US12599579B2 (en) 2016-04-19 2026-04-14 Axcess Global Sciences, Llc Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12622889B2 (en) 2016-04-19 2026-05-12 Axcess Global Sciences, Llc S-β-hydroxybutyrate esters for improving metabolic function
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
EP3275446A1 (en) * 2016-07-25 2018-01-31 Sinutron KG Prebiotic compositions comprising oligosaccharides from hyptis suaveolens
CN116268414B (zh) * 2016-12-29 2025-07-25 山东新时代药业有限公司 一种改善胃肠道功能、防治便秘的组合物及其用途
WO2018175879A1 (en) * 2017-03-24 2018-09-27 Ritter Pharmaceuticals, Inc. Methods of treating lactose intolerance and improving gastrointestinal health
WO2018181621A1 (ja) 2017-03-28 2018-10-04 味の素株式会社 腸内環境改善用飼料組成物
EP3635092A4 (en) * 2017-06-09 2021-02-24 Sami Labs Limited COMPOSITIONS AND METHODS FOR REDUCING FLATULENCE
US10485253B2 (en) 2017-08-21 2019-11-26 Mustapha Benmoussa Method of microalgal biomass processing for high-value chemicals production, the resulting composition of butyrogenic algal slowly fermenting dietary fiber, and a way to improve colon health using a slowly fermenting butyrogenic algal dietary fiber
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
WO2019113023A1 (en) * 2017-12-04 2019-06-13 The BioCollective, LLC Probiotics and methods of use
US11116745B2 (en) * 2018-01-31 2021-09-14 Deep Cell Industries, Inc. Prebiotic formulation
US10842811B2 (en) 2018-02-28 2020-11-24 The Trustees Of Columbia University In The City Of New York Inulin for preventing antibiotic resistant infection and pathogen colonization
EP3542641B1 (de) 2018-03-20 2023-07-12 Universität Hohenheim Lactulosehaltiges produkt sowie verfahren zur herstellung eines lactulosehaltigen produkts
US11318177B2 (en) * 2018-03-21 2022-05-03 Aixswiss B.V. Lactobacillus fermentum for treating fructose-related diseases
US11129802B2 (en) 2018-08-27 2021-09-28 Axcess Global Sciences, Llc Compositions and methods for delivering cannabidiol and ketone bodies
US11419836B2 (en) 2019-02-13 2022-08-23 Axcess Global Sciences, Llc Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
US10980772B2 (en) 2018-08-27 2021-04-20 Axcess Global Sciences, Llc Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US11241401B2 (en) 2020-02-06 2022-02-08 Axcess Global Sciences, Llc Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
RU2729633C2 (ru) * 2018-07-05 2020-08-11 Общество С Ограниченной Ответственностью "Валента - Интеллект" Биологически активная пищевая добавка для профилактики воспалительного заболевания кишечника и функциональных кишечных расстройств и способ ее получения
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
IT201800009675A1 (it) * 2018-10-22 2020-04-22 Lb Lyopharm Srl Metodo e kit per valutare la capacita’ di deglutizione
EP3893748B1 (en) 2018-12-10 2023-11-15 Heteron Biotechnologies, LLC Hydrogen breath analyzer and breath test method
US12414710B2 (en) 2018-12-10 2025-09-16 Anastasia Rigas Breath analyzer devices and breath test methods
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
CN114126605B (zh) 2019-06-11 2023-05-23 先进制药股份有限公司 超氧化物歧化酶可溶性纤维组合物
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11033553B2 (en) 2019-06-21 2021-06-15 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
CN114761023A (zh) * 2019-11-27 2022-07-15 格礼卡姆股份公司 Hmo混合物
US20230285477A1 (en) * 2020-07-24 2023-09-14 Beo Therapeutics Microbial therapy
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
US20220192246A1 (en) * 2020-12-22 2022-06-23 Viva Life Science, Inc. Composition and method for synbiotics supplement containing probiotics, digestive enzymes, prebiotics, yeast, protein, b vitamins, and flavoring agent
WO2023161321A1 (en) * 2022-02-25 2023-08-31 Frieslandcampina Nederland B.V. Process for preparing high purity galacto-oligosaccharide
KR102590051B1 (ko) * 2022-10-20 2023-10-16 주식회사 종근당바이오 건강한 한국인의 장내 핵심 유산균을 이용한 장내 마이크로바이옴 환경 및 장 건강 개선용 프로바이오틱스 조성물
US20260207682A1 (en) * 2022-11-15 2026-07-23 Newgen 27, Llc D/B/A Doctor's Biome Probiotic formulations and methods of use thereof
WO2025005236A1 (ja) * 2023-06-30 2025-01-02 株式会社明治 Ｆｕｓｏｂａｃｔｅｒｉｕｍ属菌の制御用組成物及びその利用
US12343432B2 (en) * 2023-07-07 2025-07-01 United Arab Emirates University Encapsulated probiotic
WO2025049896A1 (en) * 2023-09-01 2025-03-06 Prebiotic Health Sciences, Inc. Methods of reversing oxidative stress with lactulose and other prebiotic compounds
WO2025075557A1 (en) * 2023-10-02 2025-04-10 Gebze Teknik Universitesi A lactose tolerant cheese product for lactose intolerant individuals and a method of preparing this product
WO2025202246A1 (en) * 2024-03-25 2025-10-02 Innovative Food Technologies LLC Microencapsulates and uses thereof

Family Cites Families (257)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3048526A (en) 1958-08-04 1962-08-07 Wander Company Medicinal tablet
US3108046A (en) 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3627583A (en) 1969-04-29 1971-12-14 Sucrest Corp Direct compression vehicles
US3718739A (en) 1971-06-15 1973-02-27 Baxter Laboratories Inc Treating lactase deficiency with an active lactase
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4532126A (en) 1982-05-07 1985-07-30 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
US4656066A (en) 1982-12-20 1987-04-07 Warner-Lambert Company Apparatus and method for sealing capsules
US4625494A (en) 1983-04-28 1986-12-02 Pfrimmer & Co. Pharmazeutische Werke Erlangen Method and apparatus for making mixtures of pharmaceutical liquids
US4478822A (en) 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4629694A (en) 1983-07-12 1986-12-16 Cornell Research Foundation, Inc. Detecting and distinguishing between plasminogen activators
JPS6078540A (ja) 1983-10-05 1985-05-04 Kansai Runa Kk 炭酸ガス，アルコ−ル等を含有する醗酵乳の製造法
JPS6078540U (ja) 1983-11-05 1985-05-31 アルプス電気株式会社 キ−ボ−ド
JPS60221078A (ja) 1984-04-18 1985-11-05 Morinaga Milk Ind Co Ltd 有用微生物粉末の粒状製品およびその製造法
JPS6163618A (ja) 1984-09-03 1986-04-01 Akira Yamauchi 下剤
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US4671953A (en) 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
GB8601100D0 (en) 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
US4919939A (en) 1986-04-29 1990-04-24 Pharmetrix Corporation Periodontal disease treatment system
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JP2711095B2 (ja) 1986-09-27 1998-02-10 ユニチカ株式会社 ビフイドバクテリウム菌の増殖促進剤の製造法
US4800083A (en) 1986-10-20 1989-01-24 R. P. Scherer Corporation Sustained release method and product
NZ222902A (en) * 1986-12-15 1990-08-28 Yakult Honsha Kk Method for producing galactooligosaccharide
ES2061623T3 (es) 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
CA1308661C (en) 1987-06-26 1992-10-13 Masayasu Kurono AGENT FOR INHIBITING BINDING OF 5.alpha.-DIHYDRO-TESTOSTERONE WITH ANDROGEN RECEPTOR AS WELL AS PROCESS FOR OBTAINING SAME
US4806368A (en) 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
JP2518663B2 (ja) 1987-12-24 1996-07-24 株式会社ヤクルト本社 ガラクトオリゴ糖含有加工乳の製造法
JPH01296935A (ja) 1988-05-25 1989-11-30 Yakult Honsha Co Ltd オリゴ糖入りパンの製造法
JP2529588B2 (ja) 1988-05-30 1996-08-28 株式会社ヤクルト本社 複合甘味料
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US5032509A (en) 1988-10-06 1991-07-16 Kabushiki Kaisha Yakult Honsha Method of preparing galcatooligosaccharide
US4959234A (en) 1988-11-17 1990-09-25 Electric Power Research Institute Method for improving the taste, texture and mouth feel of a liquid dairy product and for concentrating same
US5223426A (en) * 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
US4935243A (en) 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
FR2640997A1 (en) 1988-12-22 1990-06-29 Ajinomoto Kk Process for the manufacture of a galactose transfer product.
JPH02207796A (ja) 1989-02-07 1990-08-17 Ajinomoto Co Inc 酵素を用いたガラクトオリゴ糖の製造法
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5219842A (en) 1989-08-29 1993-06-15 Nihon Shokuhin Kako Co., Ltd. Method of improving intestinal floras
US5013726A (en) 1989-09-12 1991-05-07 Ivy Jeffery W External analgesic lotion containing active ingredients of methyl salicylate and camphor and menthol and method of making such lotion
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
JP2724380B2 (ja) 1989-12-26 1998-03-09 松谷化学工業株式会社 ガラクトオリゴ糖の製造法
JP2729406B2 (ja) 1989-12-27 1998-03-18 松谷化学工業株式会社 難消化性ヘテロ多糖類の製造法
US5234828A (en) 1990-03-16 1993-08-10 Suntory Limited Process for producing novel heat-resistant β-galactosyltransferase
FI88856C (fi) 1990-05-18 1997-07-01 Alko Yhtioet Oy Foerfarande foer framstaellning av ett fermenterat, huvudsakligen pao havrekli baserat, levande mikroorganismer innehaollande livsmedel
JP2930370B2 (ja) 1990-05-25 1999-08-03 雪印乳業株式会社 ガラクトオリゴ糖類含有脱脂粉乳の製造方法
EP0474230B1 (en) 1990-09-05 1995-03-15 Terumo Kabushiki Kaisha Insoluble dietary fibers, method of producing the dietary fiber and foods containing the dietary fiber
JP2571734B2 (ja) 1991-08-23 1997-01-16 株式会社ヤクルト本社 乳酸菌飲料
US5225202A (en) 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
DE69229710T2 (de) 1991-11-15 2000-03-02 Kanegafuchi Kagaku Kogyo K.K., Osaka Esterbindung enthaltende Polymere für pharmazeutische Zubereitungen
CA2056167A1 (en) 1991-11-25 1993-05-26 James Joseph Miller Body dusting powder containing live bacterial culture
JP2952439B2 (ja) 1991-11-26 1999-09-27 株式会社ホーネンコーポレーション 新規飲食品素材
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
AU659896B2 (en) 1991-12-27 1995-06-01 Matsutani Chemical Industries Co., Ltd. Feed for livestock which contains galacto-oligosaccharides
US5716615A (en) 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
JP3078923B2 (ja) 1992-04-08 2000-08-21 塩水港精糖株式会社 新規分岐シクロデキストリンおよびその製造方法
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5439893A (en) 1993-05-26 1995-08-08 University Of Montana Methods for the treatment and prevention of diarrhea
US5641759A (en) 1993-05-26 1997-06-24 Purdue Research Foundation Animal husbandry methods and compositions therefor
CA2176719C (en) 1993-11-17 2007-09-18 Geoffrey Anisson Fatty acid delivery system
CA2181048C (en) 1994-01-14 2003-05-06 Lee Shahinian, Jr. A method for sustained and extended corneal analgesia
US5550106A (en) 1994-03-04 1996-08-27 Bristol-Myers Squibb Company Low buffer nutritional composition
CN1094972C (zh) 1994-05-26 2002-11-27 伯拉考公司 人类来源的乳酸杆菌菌株、它们的组合物及其应用
IT1270216B (it) 1994-06-14 1997-04-29 Recordati Chem Pharm Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
FR2723960B1 (fr) 1994-08-31 1996-10-11 Gervais Danone Co Cultures de streptococcus thermophilus a activite beta-galactosidase elevee, leur procede d'obtention, et leurs utilisations
FR2723963B1 (fr) 1994-08-31 1997-01-17 Gervais Danone Co Preparation de produits fermentes par streptococcus thermophilus, enrichis en galacto-oligosaccharides et en beta-galactosidase
US5733575A (en) 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US6241983B1 (en) 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US5531989A (en) 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5871776A (en) 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
DE19516952A1 (de) 1995-05-12 1996-11-14 Hoechst Ag Verfahren zur enzymatischen Galactosylierung von Mono- und Oligosacchariden
US5827526A (en) 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
EP0770397B1 (en) 1995-10-18 2004-04-21 Akzo Nobel N.V. Newcastle disease virus combination vaccine
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
AUPN881396A0 (en) 1996-03-20 1996-04-18 Arnott's Biscuits Limited Enhancement of microbial colonization of the gastrointestinal tract
NZ333182A (en) 1996-06-06 2000-03-27 Bifodan As Enteric coating comprising alginic acid and a water soluble binding agent for an oral preparation
US5861174A (en) 1996-07-12 1999-01-19 University Technology Corporation Temperature sensitive gel for sustained delivery of protein drugs
JPH10108647A (ja) 1996-10-08 1998-04-28 Meiji Seika Kaisha Ltd 胃切除術後患者用ミネラル補給材
JP4008974B2 (ja) 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
BR9714426A (pt) 1996-12-20 2000-04-25 Nutrinova Gmbh Processo para reforçar a intensidade adoçante e para aperfeiçoar o sabor de uma mistura de adoçantes altamente intensos
DE69600525T2 (de) 1996-12-23 1998-12-10 Sitia-Yomo S.P.A., Mailand/Milano Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
DE19701382A1 (de) 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US5906982A (en) 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
ATE323421T1 (de) 1997-07-05 2006-05-15 Nestle Sa Gefrorenes dessert, welches milchsäurebakterien und fermentierbare ballaststoffe enthält
US6093425A (en) 1997-11-21 2000-07-25 Princeton Nutrition, L.L.C. Complete nutritional milk compositions and products
US5952205A (en) 1998-02-06 1999-09-14 Neose Technologies, Inc. Process for processing sucrose into glucose and fructose
EP1076716A1 (en) 1998-05-05 2001-02-21 McNeil Speciality Products Company Division of McNeil-PPC Inc. Functional sugar polymers from inexpensive sugar sources and apparatus for preparing same
DE69920219T2 (de) * 1998-06-17 2005-09-22 New Zealand Dairy Board Bioaktive molke-eiweisshydrolysate
US7029702B2 (en) 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
WO2000013526A1 (en) 1998-09-08 2000-03-16 Societe Des Produits Nestle S.A. Milk-based powder for pets
US6139875A (en) 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
NL1010770C2 (nl) 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
IT1304170B1 (it) 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
US6572871B1 (en) 1999-01-06 2003-06-03 W. Edward Church Pain treatment method and apparatus using heating wrap and analgesic cream
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
US6258380B1 (en) 1999-03-05 2001-07-10 Banner Pharmacaps, Inc. Chewable soft capsule
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
WO2000061155A1 (en) 1999-04-08 2000-10-19 Khan Airudin S Composition, containing sublimed sulfur, for the treatment of lactose intolerance
US6706287B2 (en) 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
US20040161422A1 (en) 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
JP4273277B2 (ja) 1999-06-30 2009-06-03 大塚製薬株式会社 オリゴ糖補給組成物
US6468525B1 (en) 1999-08-10 2002-10-22 Renew Life, Inc. Probiotic formulation
WO2001017875A1 (en) 1999-09-02 2001-03-15 Snap Pak Industries (Aust) Pty Ltd Dispensing sachet by bending and method of sachet manufacture
US6833260B1 (en) 1999-10-08 2004-12-21 Protein Scientific, Inc. Lactose hydrolysis
WO2001032199A1 (en) 1999-11-05 2001-05-10 Rogoff Joseph A Secretin and secretin pharmaceuticals for treating lactose intolerance
DE19958985A1 (de) 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
EP1062873A1 (en) 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
DE19962427A1 (de) 1999-12-22 2001-07-12 Nutrinova Gmbh Verkapselte multifunktionelle, biologisch aktive Nahrungsmittelkomponente, Verfahren zu ihrer Herstellung und ihre Anwendung
US6420473B1 (en) 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
MXPA02008016A (es) 2000-02-17 2002-11-29 American Home Prod Formulacion nutricional que contiene substancias prebioticas.
DE60107544T2 (de) 2000-03-01 2005-12-15 Société des Produits Nestlé S.A. Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort
US6368641B1 (en) 2000-04-28 2002-04-09 Hartz International Inc. Lactic acid bacteria and food products
EP1175905A1 (en) 2000-07-24 2002-01-30 Societe Des Produits Nestle S.A. Nutritional Composition
WO2002018614A1 (en) 2000-08-30 2002-03-07 Amano Enzyme Inc. METHOD OF ELEVATING YIELD OF OLIGOSACCHARIDES CONTAINING α-GALACTOSYL AND ANTI-CANDIDA COMPOSITIONS
GB2369777B (en) 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
IL156490A0 (en) 2000-12-18 2004-01-04 Probiohealth Probiotic compounds derived from lactobacillus casei strain ke01
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
FI109602B (fi) 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
US20030185811A1 (en) 2001-02-06 2003-10-02 Steve Teasdale Herbal extract and preparation thereof
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
JP3921175B2 (ja) 2001-04-02 2007-05-30 わかもと製薬株式会社 口腔内疾患の予防及び／又は治療用組成物
US20030017192A1 (en) 2001-06-19 2003-01-23 Hanny Kanafani Process for producing extended shelf-life ready-to-use milk compositions containing probiotics
EP1429620A1 (en) 2001-08-31 2004-06-23 Nutricopia, Inc. Nutritional frozen dessert and methods of menufacture
DE60231322D1 (de) 2001-11-12 2009-04-09 Mars Inc Nahrungsmittel für katzen und hunde
US6884445B2 (en) 2001-12-20 2005-04-26 N.V. Nutricia Matrix-forming composition containing pectin
US6989166B2 (en) 2001-12-20 2006-01-24 N.V. Nutricia Soft drink replacer
KR20030064030A (ko) 2002-01-25 2003-07-31 주식회사 푸코 위액 및 담즙산에 대한 내성이 높아 장내 생존력이 우수한한국인 분변 유래 유용 프로바이오틱 생균 및 그의 용도
US7101565B2 (en) 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
DE20202562U1 (de) 2002-02-19 2002-05-23 Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
US20050074442A1 (en) 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
FR2838452B1 (fr) * 2002-04-10 2004-07-09 Eurodia Ind Procede de production en continu de galacto oligosaccharides
SE0201214D0 (sv) 2002-04-23 2002-04-23 Jafar Mahdavi Multicultural fermented yoghurt
CN100528169C (zh) * 2002-05-31 2009-08-19 天野酶株式会社 抗炎剂、变应性疾病预防剂或改善剂及功能性食品
WO2003104473A2 (de) 2002-06-07 2003-12-18 Südzucker Aktiengesellschaft Galactosyl-isomalt, verfahren zu seiner herstellung und verwendung
EP1374878A1 (en) 2002-06-20 2004-01-02 N.V. Nutricia Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
US20090022852A1 (en) 2002-06-21 2009-01-22 Dnp Canada Inc. Liquid Compositions Comprising Non-Digestible Oligosaccharides and Green Tea Catechins
SI1565547T2 (sl) 2002-06-28 2013-02-28 Biosearch S.A. Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba
DK1530642T3 (da) 2002-08-06 2010-03-08 Danisco Brug af lactobacillus til fremstilling af exopolysaccharider i fødevarer og farmaceutiske sammensætninger
ITBO20020564A1 (it) 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
FI119429B (fi) 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset
CA2506932A1 (en) 2002-10-22 2004-05-06 University Of Vermont And State Agriculture College Symbiotic food products comprising oats and methods for manufacturing the same
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
EP1596872B1 (en) 2003-01-24 2011-06-22 Flora Technology Inc. Compositions and methods for restoring bacterial flora
US20050180962A1 (en) 2003-01-30 2005-08-18 Eyal Raz Inactivated probiotic bacteria and methods of use thereof
US7166451B1 (en) 2003-02-24 2007-01-23 The Ohio State University Immobilization of enzyme on a fibrous matrix
GB0308104D0 (en) 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
FI20030610A0 (fi) 2003-04-22 2003-04-22 Raisio Benecol Oy Syötävä tuote
US20040213828A1 (en) 2003-04-23 2004-10-28 Smith David J. Pain relief lollipop compositions and methods
US20040265279A1 (en) 2003-05-08 2004-12-30 Timothy Dinan Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
US7291607B2 (en) 2003-05-20 2007-11-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Isomaltooligosaccharides from Leuconostoc as neutraceuticals
CN1863463B (zh) 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
PL1644482T5 (pl) * 2003-06-30 2015-05-29 Clasado Inc Nowa kompozycja galaktooligosacharydów i jej wytwarzanie
GB0315266D0 (en) * 2003-06-30 2003-08-06 Clasado Inc Novel galactooligosaccharide composition and the preparation thereof
WO2005013721A1 (en) 2003-07-15 2005-02-17 Nestec S.A. High fibre high calorie liquid or powdered nutritional composition
KR101095712B1 (ko) 2003-08-21 2011-12-20 오츠카 세이야쿠 가부시키가이샤 점막 면역 부활 작용을 갖는 유산균
ATE306821T1 (de) 2003-09-18 2005-11-15 Pm Int Ag Pulver zum ansatz für eine probiotische joghurtspeise
GB0321996D0 (en) 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
GB0322358D0 (en) 2003-09-24 2003-10-22 Bioprogress Technology Ltd Improvements in powder compaction and enrobing
CA2540105A1 (en) 2003-09-25 2005-03-31 Natco Pharma Limited Enteric soft gelatin capsule containing esomeprazole and method of preparation
KR100492455B1 (ko) * 2003-09-26 2005-05-30 주식회사 비피도 로바타바이러스 억제활성을 갖는 신균주 비피도 박테리움 롱검 에이알81 및 이로부터 분리된 활성단백질
WO2005035781A1 (en) 2003-10-02 2005-04-21 Novartis Ag Prebiotic effect analysis
PL1733730T3 (pl) 2003-10-24 2008-12-31 Nutricia Nv Oligosacharydy immunomodulujące
JP4740866B2 (ja) 2003-10-24 2011-08-03 ナムローゼ フェンノートシャップ ニュートリシア 乳児向けシンバイオティック組成物
US6936598B2 (en) 2003-11-21 2005-08-30 Hill's Pet Nutrition, Inc. Composition and method
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
EP1600060A1 (en) 2004-05-25 2005-11-30 Cognis IP Management GmbH Oral and/or topical compositions comprising prebiotics and fatty acid
EP1614357A1 (en) 2004-07-10 2006-01-11 Cognis IP Management GmbH Dietary supplements comprising prebiotics and fatty acid
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
US7435431B2 (en) 2004-07-28 2008-10-14 Abbott Laboratories Method for controlling body weight in estrogen-insufficient women
US20060040001A1 (en) 2004-07-28 2006-02-23 Johnson Catherine D Nutritional compositions and methods for treating or preventing osteoporosis
BRPI0418986A (pt) * 2004-08-05 2007-12-11 Anidral Srl cepas bacterianas bifidobacterium produtoras de ácido fólico, formulações e seus usos
US20060034993A1 (en) 2004-08-10 2006-02-16 Katrin Saelzer Compositions for improved mouthfeel in reduced-sugar or sugar-free foodstuffs and associated methods and articles therefrom
DK1629850T4 (da) 2004-08-24 2013-07-01 Nutricia Nv Næringssammensætning indeholdende ufordøjelige oligosaccharider
EP1629727A1 (en) 2004-08-24 2006-03-01 N.V. Nutricia Composition containing fermentable polysaccharides
US20060093592A1 (en) 2004-10-04 2006-05-04 Nutracea Synbiotics
ES2305894T3 (es) 2004-11-12 2008-11-01 N.V. Nutricia Alimentacion transicional liquida para bebes.
EP1811867A2 (en) * 2004-11-12 2007-08-01 N.V. Nutricia Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses
JPWO2006054710A1 (ja) * 2004-11-22 2008-06-05 サンスター株式会社 最大消化管通過時間改善剤、消化管通過時間改善剤及び大腸癌予防剤
CA2532062A1 (fr) 2005-01-14 2006-07-14 Nutrinor Cooperative Agro-Alimentaire Du Saguenay Lac St-Jean Composition alimentaire pour maintien et retablissement des fonctions digestives
PE20061041A1 (es) * 2005-01-28 2006-10-12 Lilly Co Eli Formulaciones y regimen de dosificacion para moduladores alfa de ppar
WO2006088923A2 (en) 2005-02-15 2006-08-24 Gorbach Sherwood L A food containing a probiotic and an isolated beta-glucan and methods of use thereof
PT1926394T (pt) 2005-02-21 2020-05-22 Nestle Sa Mistura de oligossacáridos
PL2805625T5 (pl) 2005-02-28 2023-03-13 N.V. Nutricia Kompozycja odżywcza z prebiotykami i probiotykami
CN101175416A (zh) 2005-04-06 2008-05-07 诺瓦提斯公司 从营养方面改善葡萄糖控制和胰岛素作用的方法和组合物
US20060240148A1 (en) 2005-04-13 2006-10-26 The Dannon Company, Inc. High-fiber dairy product
CN101163415B (zh) 2005-04-21 2013-03-13 N.V.努特里奇亚 用于hiv患者的营养补充剂
EP1714562A1 (en) 2005-04-22 2006-10-25 N.V. Nutricia Process for drying uronic acid oligosaccharides
EP1728852A1 (en) 2005-05-30 2006-12-06 Chiron Behring GmbH & Co. KG Fermenter system for biotechnical processes
DE202005009120U1 (de) 2005-06-10 2005-11-10 Peterik, Josef Bifidoaktiver probiotischer Joghurt
HUP0500582A1 (hu) 2005-06-13 2007-08-28 Csaba Jozsef Dr Jaszberenyi Szinergetikus élettani hatású élelmiszerek, élelmiszer-adalékok és táplálék-kiegészítõk vagy takarmányadalékok
AT501919B1 (de) 2005-06-14 2008-09-15 Erber Ag Probiotischer, gesundheits- bzw. leistungsfördernder futtermittel- und/oder trinkwasserzusatz für tiere sowie seine verwendung
DE102005033630A1 (de) 2005-07-19 2007-01-25 Humana Gmbh Calcium-Peptid-Komponente
FR2889958A1 (fr) 2005-08-25 2007-03-02 Lyoct Sa Lab Utilisation d'un symbiotique pour le traitement de la dermatite atopique
DE102005046237A1 (de) 2005-09-28 2007-04-05 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
EP1959977A4 (en) * 2005-11-07 2010-03-31 Russell M Jaffe COMPOSITIONS FOR REGULATING INTESTINAL DISORDERS AND METHODS OF USE THEREOF
AU2006311601A1 (en) * 2005-11-07 2007-05-18 Elixir Pharmaceuticals, Inc. Combinations of metformin and meglitinide
GB0522740D0 (en) 2005-11-08 2005-12-14 Clasado Inc Process for the production of oligosaccharides
US20070134391A1 (en) 2005-11-23 2007-06-14 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Autoimmune Disorders and Compositions Sweetened Therewith
RU2450815C2 (ru) 2005-12-16 2012-05-20 Н.В. Нютрисиа Применение растворимых пищевых волокон против мышечной атрофии
EP1832179B1 (en) 2005-12-20 2018-11-07 N.V. Nutricia Carbohydrate composition and flat glucose response
EP1803358A1 (en) 2005-12-28 2007-07-04 Laboratorios Ordesa, S.L Infant immunological formula
WO2007090894A1 (en) 2006-02-10 2007-08-16 Nestec S.A. Oligosaccharide mixture
MX2008010440A (es) 2006-02-13 2008-11-12 Mcneil Nutritionals Llc Composiciones lacteas con menor contenido de lactosa y metodos relacionados.
US9005682B2 (en) 2006-03-07 2015-04-14 Nestec S.A. Synbiotic mixture
US8784886B2 (en) 2006-03-09 2014-07-22 GlaxoSmithKline, LLC Coating capsules with active pharmaceutical ingredients
BRPI0708701A2 (pt) 2006-03-10 2011-06-07 Nutricia Nv uso de um sacarìdeo não digerìvel solúvel em água
JP5482982B2 (ja) * 2006-03-13 2014-05-07 レンティカッツ， アー．エス． 酵素又は微生物をポリビニールアルコールゲルに固定した形状の生体触媒の工業生産法、その使用及びその生産装置
WO2007114683A1 (en) 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
JP5544164B2 (ja) 2006-05-02 2014-07-09 ナショナル リサーチ カウンセル オブ カナダ カンピロバクター・ジェジュニ（ＣａｍｐｙｌｏｂａｃｔｅｒＪｅｊｕｎｉ）由来のα−１，４−ガラクトシルトランスフェラーゼ（ＣｇｔＤ）
EP2269465A1 (en) 2006-05-03 2011-01-05 Probiotical S.p.a. Compositions comprising Bifidobacterium adolescentis
US20090118226A1 (en) 2006-05-30 2009-05-07 Kazunari Ushida Intestinal eosinophil-suppressing composition
CN101926831A (zh) 2006-06-26 2010-12-29 青岛东海药业有限公司 凝结芽胞杆菌在制备防治便臭和便臭中毒综合征组合物制剂中的应用
CN101095698B (zh) 2006-06-26 2010-12-01 青岛东海药业有限公司 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途
WO2008015374A2 (en) 2006-08-04 2008-02-07 Shs International Ltd Protein free formula
EP1887017A1 (en) 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate
EP1897449A1 (en) 2006-09-09 2008-03-12 Cognis IP Management GmbH Oral and /or topical compositions
ES2373592T3 (es) 2006-10-02 2012-02-06 Friesland Brands B.V. Inhibición de toxinas del cólera por galactooligosacáridos (gos).
WO2008054193A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Nutritional products that comprise saccharide oligomers
WO2008072056A1 (en) * 2006-12-14 2008-06-19 Pfizer Limited Use of mtp inhibitors for the treatment of obesity using low doses and dose-escalation
US20080254166A1 (en) 2007-01-25 2008-10-16 Potter Susan M Food Additives Containing Combinations of Prebiotics and Probiotics
US20100068213A1 (en) 2007-02-20 2010-03-18 N.V. Nutricia Selected colostrum for treatment of intestinal barrier function disorders
US20100063002A1 (en) 2007-03-13 2010-03-11 Bernd Stahl Method of improving skills with a composition comprising non-digestible saccharide
PT103714B (pt) 2007-04-11 2020-07-28 73100 - Setenta E Três Mil E Cem, Lda. Processo para a obtenção de um polímero à base de galactose
EP2137305B1 (en) 2007-04-20 2014-11-05 National Research Council Of Canada Engineered versions of cgtb (beta-1,3- galactosyltransferase) enzymes, with enhanced enzymatic properties
EP1988096A1 (en) 2007-04-26 2008-11-05 Laboratorios Ordesa, S.L Process for preparing a galactooligosaccharides powder
WO2008135959A1 (en) 2007-05-04 2008-11-13 Alimentary Health Limited An exopolysaccharide
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
ITMI20071214A1 (it) * 2007-06-15 2008-12-16 S I I T Srl Servizio Internazi Composizioni a base di componenti prebiotici ed immunogenici per la prevenzione e il trattamento di disturbi gastroenterici da disbiosi e/o alterazioni della normale flora intestinale
WO2008156354A1 (en) 2007-06-21 2008-12-24 N.V. Nutricia Modulation of intestinal flora of hiv patients
EP2173196B1 (en) 2007-07-06 2011-02-16 N.V. Nutricia Use of probiotics and fibers for diarrhoea
EP2030623A1 (en) 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
US20110223248A1 (en) 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
WO2009113030A2 (en) * 2008-03-12 2009-09-17 Tata Chemicals Ltd. Process for the production of galactooligosaccharides by free cells
CN101366734A (zh) 2008-06-18 2009-02-18 辽宁大生药业有限公司 合生素药物组合物
US20110189148A1 (en) 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
CN101396048A (zh) 2008-11-25 2009-04-01 内蒙古蒙牛乳业（集团）股份有限公司 一种富含低聚半乳糖奶的生产方法
CA2984935C (en) 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2405918B2 (en) 2009-03-13 2020-09-02 The Regents of The University of California Prebiotic oligosaccharides
CA2763384C (en) * 2009-05-27 2014-07-08 Clasado Inc Use of a composition of a mixture of galactooligosaccharides for preventing diarrhoea
IT1395068B1 (it) 2009-08-07 2012-09-05 Inalco Spa Processo per la produzione di galatto-oligosaccaridi ultrapuri
US20110189342A1 (en) 2010-02-01 2011-08-04 Jeong Hea-Seok High-purity galactooligosaccharides and uses thereof
US20130316972A1 (en) 2010-02-17 2013-11-28 Ritter Pharmaceuticals, Inc. Prebiotic Formulations and Methods of Use
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US10221432B2 (en) 2010-06-16 2019-03-05 Conocophillips Company In situ methanogenesis modeling and risk analysis
WO2013082562A1 (en) 2011-11-30 2013-06-06 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use

Also Published As

Publication number Publication date
JP6882931B2 (ja) 2021-06-02
CA2752800A1 (en) 2010-09-02
US20130165407A1 (en) 2013-06-27
CA2984935C (en) 2021-01-12
US20150133398A1 (en) 2015-05-14
ES2600960T3 (es) 2017-02-13
WO2010098822A1 (en) 2010-09-02
US20180250324A1 (en) 2018-09-06
JP2019123752A (ja) 2019-07-25
GB2480042B (en) 2014-03-12
US20130177612A1 (en) 2013-07-11
SG10201901259RA (en) 2019-03-28
CN107320480A (zh) 2017-11-07
US20150374739A1 (en) 2015-12-31
US9370532B2 (en) 2016-06-21
AU2017200343A1 (en) 2017-02-02
US9775860B2 (en) 2017-10-03
KR20170053733A (ko) 2017-05-16
IL256924A (en) 2018-03-29
US20160367579A1 (en) 2016-12-22
EP2400839B1 (en) 2016-09-07
GB2480042A (en) 2011-11-02
AU2017200343B2 (en) 2018-11-22
US20150374728A1 (en) 2015-12-31
US20130244969A1 (en) 2013-09-19
EP2400839A4 (en) 2012-08-22
GB201114995D0 (en) 2011-10-12
CA2752800C (en) 2017-12-05
US8492124B2 (en) 2013-07-23
CN102404990A (zh) 2012-04-04
SG2014014435A (en) 2014-07-30
KR20110124780A (ko) 2011-11-17
KR20190000937A (ko) 2019-01-03
AU2010218439B2 (en) 2016-10-20
IL214806B (en) 2018-04-30
US9808481B2 (en) 2017-11-07
CA2984935A1 (en) 2010-09-02
JP2016065069A (ja) 2016-04-28
SG173832A1 (en) 2011-09-29
US9579340B2 (en) 2017-02-28
IL256924B (en) 2020-06-30
US20100215738A1 (en) 2010-08-26
IL214806A0 (en) 2011-11-30
EP2400839A1 (en) 2012-01-04
JP2012518635A (ja) 2012-08-16
AU2010218439A1 (en) 2011-09-08
ZA201106066B (en) 2017-08-30
JP2017132815A (ja) 2017-08-03

Similar Documents

Publication Publication Date Title
HRP20190137T1 (hr) Stabilne formulacije polipeptida i njihova uporaba
IL256924B (en) Prebiotic formulations and methods of using them
PT2424372T (pt) Composições antimicrobianas e métodos de uso relacionados
IL223725B (en) Formulations of rifaximin and uses thereof
BRPI1005670A2 (pt) composições adjuvantes e métodos de uso
BRPI1009847A2 (pt) conectores médicos e métodos de uso
BR112012013148A2 (pt) formulação farmacêutica e uso
BRPI1012333A2 (pt) atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
PL3812360T3 (pl) Związki monochlorotrifluoropropenu oraz kompozycje i sposoby ich zastosowania
EP2563372A4 (en) PREBIOTIC FORMULATIONS AND USE METHOD THEREFOR
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
PL3121280T3 (pl) Antysensowne kompozycje i sposoby ich wytwarzania i stosowania
BR112013014231A2 (pt) composição de higiene pessoal e uso da composição de higiene pessoal
PT2585437E (pt) Compostos de tioacetato, composições e métodos de uso
EP2515946A4 (en) NANOCONJUGATE AND NANOCONJUGATE FORMULATIONS
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
BRPI1007175A2 (pt) Polipeptídeos hidroxifenilpriruvato dioxigenase mutantes e métodos de uso
DK2531181T3 (da) Formuleringer af rasagilin med forlænget afgivelse og anvendelser deraf
BRPI1007494A2 (pt) composto e uso do mesmo
BR112012018329A2 (pt) agentes de coloração e métodos de uso destes
BRPI1014544A2 (pt) anticorpors anti-il-17f e metodos de uso dos mesmos
BR112013010988A2 (pt) composição fluída e uso
BR112013006016A2 (pt) compostos de azabenzotiazol, composições e métodos de uso
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
GB201411462D0 (en) Prebiotic formulations and methods of use

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL